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H I G H L I G H T S
 Cytotoxicity and induction of inﬂammation by selected limonene oxidation products were assessed in human lung cell lines.
 4-OPA demonstrated the strongest cell viability destruction of A549 and 16HBE14o- cells.
 IPOH was stimulating IL-6, IL-8 and TNF-a release from both A549 and 16HBE14o- cell lines.
 4-OPA and 4-AMCH were inhibiting IL-6, IL-8, TNF-a release in 16HBE14o-cells, but not in A549 cells.
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A B S T R A C T
Limonene, a monoterpene abundantly present in most of the consumer products (due to its pleasant
citrus smell), easily undergoes ozonolysis leading to several limonene oxidation products (LOPs) such as
4-acetyl-1-methylcyclohexene (4-AMCH), 4-oxopentanal (4-OPA) and 3-isopropenyl-6-oxoheptanal
(IPOH).
Toxicological studies have indicated that human exposure to limonene and ozone can cause adverse
airway effects. However, little attention has been paid to the potential health impact of speciﬁc LOPs, in
particular of IPOH, 4-OPA and 4-AMCH.
This study evaluates the cytotoxic effects of the selected LOPs on human bronchial epithelial
(16HBE14o-) and alveolar epithelial (A549) cell lines by generating concentration-response curves using
the neutral red uptake assay and analyzing the inﬂammatory response with a series of cytokines/
chemokines.
The cellular viability was mostly reduced by 4-OPA [IC50 = 1.6 mM (A549) and 1.45 mM (16HBE14o-)]
when compared to IPOH [IC50 = 3.5 mM (A549) and 3.4 mM (16HBE14o-)] and 4-AMCH [IC50 could not be
calculated]. As a result from the inﬂammatory response, IPOH [50 mM] induced an increase of both IL-6
and IL-8 secretion in A549 (1.5-fold change) and in 16HBE14o- (2.8- and 7-fold change respectively). 4-
OPA [50 mM] treatment of A549 increased IL-6 (1.4-times) and IL-8 (1.3-times) levels, while in 16HBE14o-
had an opposite effect. A549 treated with 4-AMCH [50 mM] elevate both IL-6 and IL-8 levels by 1.2-times,
while in 16HBE14o- had an opposite effect.
Based on our results, lung cellular injury characterized by inﬂammatory cytokine release was observed
for both cell lines treated with the selected chemicals at concentrations that did not affect their cellular
viability.
ã 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-
ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The prevalence of respiratory diseases, asthma and allergies in
large populations has increased substantially in recent decades
(Tarlo and Lemiere, 2014; Melén et al., 2008). This phenomenon
has been associated, among other factors, to the several chemicals
used in various commercially available consumer products (e.g.
cleaning agents, air-fresheners) that are released into the everyday
environment (Crinnion, 2012; Heinrich, 2011; Patelarou et al.,
2015; Choi et al., 2010; U.S. Food and Drug Administration, 2009).
Limonene, a common terpene added to a variety of consumer
products intended for occupational and personal use, is a very
reactive compound towards ozone (O3), hydroxyl (OH) and peroxy
(RO2) radicals. Its reaction with ozone leads to various limonene
oxidation products (LOPs) such as 4-acetyl-1(+/) methylcyclo-
hexene (4-AMCH), 4-oxopentanal (4-OPA) and 3-isopropenyl-6-
oxoheptanal (IPOH) (Hakola et al., 1994; Wells, 2012; Forester and
Wells, 2009). Physico-chemical properties of the selected LOPs are
summarized in Table 1.
The presence of 4-OPA has been detected in the forestal
atmosphere ranging from 180 to 1570 ng m3 (44–384 pptv)
(Matsunaga et al., 2004), in a simulated indoor air ofﬁce at levels
around of 2.3 ppb (ozone concentration was 16 ppb) (Wisthaler
and Weschler, 2010) and in a simulated aircraft cabin up to 7 ppb
(ozone concentration was 61–77 ppb) (Weschler et al., 2007).
Nørgaard et al. (2014) measured the concentrations of 4-OPA, IPOH
and 4-AMCH in ﬁve european ofﬁces using different ﬂoor cleaning
agents (containing high and low total volatile organic compounds
(VOCs)). Before the replacement of a regular ﬂoor cleaning agent
(high total VOCs) and independently of the countries where
measurements were performed, concentrations of 4-OPA, IPOH,
and 4-AMCH up to 18 mg m3, 10 mg m3 and 0.1 mg m3,
respectively were found (Nørgaard et al., 2014).
Although several studies have indicated that humans or
animals exposure to terpene ozonolysis reaction products is
associated with respiratory diseases (e.g. asthma) (Sundell et al.,Table 1
Physico-chemical properties of selected limonene ozonolysis products: 4-acetyl-1-meth
OPA) (ChemSpider web page, 2016).
LOPs CAS no. MW Vapor press
4-acetyl-1-methylcyclohexene C9H14O, (4-AMCH) 609009-1 138.21 0.568 
3-isopropenyl-6-oxo-heptanal C10H16O2, (IPOH) 708679-5 168.23 1.3 
4-oxopentanal C5H8O2, (4-OPA) 62696-0 100.12 1.3 2004) and cardiovascular disease (Uzoigwe et al., 2013; Pope et al.,
2004), only a few studies (including both in vivo and in vitro
experiments) available in the literature directly address the impact
of selected LOPs on human health.
An in vivo study has been carried out in a head out mouse
bioassay where the respiratory effects caused by 4-OPA, IPOH, 4-
AMCH were investigated (Wolkoff et al., 2013). Based on the
different respiratory parameters such as time of brake (TB), time of
inspiration/expiration (TI/TE) and mild expiratory ﬂow rate, the
authors reported that IPOH might be classiﬁed as a sensory irritant
as observed by the elongation of TB, and with an estimated no
observed (adverse) effect level (NO(A)EL) of around 1.6 ppmv,
while for 4-AMCH, the NOEL for sensory irritation was established
to be around 13 ppmv. When mice were exposed to 4-OPA, effects
such as airﬂow limitation, sensory and pulmonary irritation were
noticed, with an estimate for sensory irritation of around 3.4 ppmv.
Anderson et al. have examined the inﬂammatory and allergic
responses in mice exposed to 4-OPA through both dermal and
pulmonary routes of exposure (Anderson et al., 2012). Using
relatively high doses (0.08–1.97 mM for dermal exposure), the
authors identiﬁed 4-OPA as being irritant (e.g. at 1.97 mM 4-OPA,
p < 0.01) and sensitizer (e.g. 0.02 mM, p < 0.01). Pulmonary toxicity
in mice following exposure to 0.08 mM 4-OPA, enhanced airway
responsiveness, neutrophil and lymphocytes inﬂux, and interfer-
on-g production by lung-associated lymph nodes.
On the other hand, one in vitro study assessed the potential
inﬂammatory capacity of 4-OPA by exposing the pulmonary
epithelial cells (A549) to a gas phase containing 65 ppm 4-OPA
(Anderson et al., 2010). Inﬂammatory markers levels of IL-8 and
TNF-alpha were both found to be elevated after 4-OPA exposure at
all time points (8, 12, 24 h), while IL-6 and GM-CSF signiﬁcantly
increased at 12 h (e.g. 1059 pg mL1 for IL-6 and 17 pg mL1 for GM-
CSF).
The aim of the present study therefore was to investigate the
inﬂammatory effects of 4-OPA, IPOH and 4-AMCH on human
pulmonary cell lines: bronchial epithelium (16HBE14o-) andylcyclohexene (4-AMCH), 3-isopropenyl-6-oxo-heptanal (IPOH), 4-oxopentanal (4-
ure mmHg Boiling point C Water solubility mg L1 Structure
205–206 811
80.5–82/
1 mm Hg
2920
100–105/
20 mm Hg
50000
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the basis of their stability compared to other limonene ozonolysis
products such as peroxides, their general abundance with high
ozone or hydroxyl radical yields (Forester and Wells, 2009) and on
the hypothesis that terpene reaction products containing multiple
oxygen groups such as dicarbonyls may cause inﬂammatory and
respiratory sensitizing effects and/or skin irritation (Pope et al.,
2004; Wolkoff et al., 2013; Anderson et al., 2012; Anderson et al.,
2010; Anderson et al., 2007).
The human lung cell line A549 is commonly used as a Type II
pulmonary epithelial cell model, and was thus selected to assess
the lung toxicity of the three LOPs. A recent overview of cell-based
models for pulmonary research is available (Gordon et al., 2015).
The human bronchial epithelial cell line 16HBE14o- was included
in these experiments, due to its capacity to react to inﬂammatory
stimuli like the primary human bronchial epithelial cells (BéruBé
et al., 2010).
Biological endpoints such as cell viability assessed by neutral
red uptake assay (NRU) and production of inﬂammatory mediators
such as IL-8, IL-6, TNF-alpha, IL-10 and IL-13 were determined after
24 h at different concentrations for each chemical. Moreover, gas
chromatography-ﬂame ionization detection (GC-FID) was used to
check chemicals stability in the culture medium.
2. Materials and methods
2.1. Chemical reagents and materials
Acetonitrile, 4-oxopentanal (4-OPA), 3-isopropenyl-6-oxohep-
tanal (IPOH) and 4-acetyl-1-methylcyclohexene (4-AMCH), sodi-
um dodecyl sulphate were obtained from Sigma Aldrich (Sigma
Aldrich, St. Louis MO, USA).
2.2. Biological reagents and materials
Roswell Park Memorial Institute medium (RPMI 1640), Mini-
mum Essential Medium (MEM), fetal bovine serum (FBS),
penicillin-streptomycin, 0.25% trypsin/EDTA, phosphate buffered
saline (PBS) and 4-2-hydroxyethyl-1-piperazinyl-ethanesolfonic
acid (HEPES) were purchased from Invitrogen (USA). Mammalian
protein extraction reagent (M-PER) was purchased from Thermo
Fischer (Italy).
The human lung epithelial carcinoma cell line (A549) was
obtained from American Type Culture Collection (ATCC #: CCL-
185). The human bronchial epithelial cell line (16HBE14o-) was
kindly provided for research purposes by Dr. Dieter C. Gruenert
(Cardiovascular Research Institute at the University of California,
San Francisco, Calif., USA).
2.3. Analytical methods used
2.3.1. GC-FID operating conditions to evaluate the chemical stability of
4-OPA, 4-AMCH, IPOH in the culture medium
The stability of chemicals prepared into the culture medium was
analyzed using an Agilent GC 6890 with a liquid injection
autosampler. The detection was performed by means of ﬂame
ionization detector (FID) at 250 C. The injector was set-up in split
mode at 250 C, with a split ratio of 1:20. The column used was a J&W
HP-5MS, 5% Phenyl Methyl Siloxane, 30 m  0.25 mm i.d. with 1 mm
ﬁlm thickness (J&W Scientiﬁc, USA). The GC oven was programmed
as follows: column oven temperature was initially 40 C; hold for
7.5 min, and increased to 90 C at the rate of 4 C/min, and to 300 C at
the rate of 15 C/min, hold for 2 min. Heliumwasused ascarrier gasat
1.5 mL min1. Sample was injected by the instrument’s autosampler
with injection volume of 1 ml. The syringe was cleaned between
injections with water and acetonitrile.The analytical method was calibrated with standard solution
prepared in acetonitrile with a concentration ranging from 0.2 to
500 mg mL1. The test sample solutions (chemicals solubilized into
culture medium) were prepared by considering two fetal bovine
serum’s concentration added to the culture medium: one with 10%
and another with 1%.
2.3.2. Samples preparation
The glass vials containing aliquots of chemicals prepared in
culture medium or acetonitrile were kept at 37 +/1 C, with 5%
CO2 and 95% humidity for 24 h (the same incubator conditions
were also used during cell exposure). Before analysing the test
sample solution aliquots at given time intervals 1, 2, 3 and 24 h,
acetonitrile (v/v, 1:100) was added to both test solutions to
precipitate the proteins. Therefore, the sample solution was
centrifuged at 10 000 rpm for 10 min in order to eliminate the
precipitate. The chromatographic peak areas of the target
chemicals solubilized into culture medium was compared to the
corresponding peak areas of the standards prepared in acetonitrile.
2.4. In-vitro methods used
2.4.1. Cell culture maintenance and chemical exposure
A549 cell line was grown in RPMI 1640 medium containing 10%
FBS and antibiotics (penicillin 100 U mL1 and streptomycin
100 mg mL1), while 16HBE14o- cell line was maintained in
MEM medium with 10% FBS, antibiotics and 1% L-glutamine. Both
cell lines were kept at 37 C, 5% CO2 in humidiﬁed air (relative
humidity 95%). The cells were harvested with trypsin/EDTA and
seeded as 150 ml/well to a density of 3 104 cells mL1 into a 96-
well plate and incubated overnight.
Target chemicals were dissolved into the culture medium
containing 1% FBS and later diluted by serial dilutions to obtain ten
different concentrations ranging from 0.2 to 115 mM (4-OPA),
0.03–17.5 mM (IPOH) and 0.01–5.8 mM (4-AMCH). The highest
concentration was determined by the aqueous solubility of
chemicals. The cell culture medium from the 96-well plates was
aspirated and 150 ml of each dilution was added to the plates in six
replicates. Cell negative control (e.g. culture medium with cells),
blanks (culture medium without cells) were used for the
calculations (e.g. the blanks were used to correct the absorbance
values), while the cell positive control (e.g. sodium dodecyl
sulphate) was considered to decide whether the experiment can be
accepted. The cell cultures were incubated for 24 h and thereafter
the NRU assay was carried out to determine cell viability.
2.4.2. Cellular viability by Neutral red uptake assay
According to the NRU protocol (Anon. INVITTOX, 2008, DB-ALM
protocol 78), after cell exposure to the target chemicals (24 h), cells
were washed with prewarmed PBS (150 ml/well). The washing
solution was removed and the neutral red dye was added (100 ml/
well) to both 16HBE14o- andA549 cellsand incubatedfor 3 h at37 C.
Afterwards, the plates were washed with PBS (150 ml/well), followed
by the addition of an acetic acid/water/ethanol (1:49:50, v/v/v)
solution (150 ml/well). During the incubation with the acetic/water/
ethanol solution, the plates were shaken for 10 min. Then, thosewere
allowed to incubate for 30 min at room temperature prior to the
measurement of the absorbance at 540 nm.
2.4.3. Inﬂammatory response measured by cytokine/chemokines
assays
Cell culture supernatants, previously collected (step done
before washing the cells with prewarmed PBS prior to the addition
of neutral red dye), were used to quantify the production of
cytokines using a MILLIPLEX MAP Kit (HCYTOMAG-60K, Millipore,
Billerica, MA), according to manufacturer’s protocol. This approach
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cytokines/chemokines: IL-6, IL-8, TNF-alpha, IL-10 and IL-13. The
plate was ran immediately on a Luminex1 100TM/200TM platform
(Luminex Corporation) with xPONENT 3.1 software. Additionally to
the negative (culture medium with and without cells) and positive
(lipopolysaccharide: LPS O113:H10) controls, the tested chemicals
solubilized into the culture medium were added to the plate to
overcome possible chemical’s interference with the assay.
2.5. Statistical analysis
At least three independent experiments were performed for
each chemical. The cytotoxicity of the tested chemicals evaluated
by NRU assay was expressed as the percentage viability (uptake of
neutral red dye by the lysosomes) compared with controls in terms
of its IC50 (the half maximal concentration of a chemical that
causes 50% inhibition of growth), which was calculated from the
concentration-response curves by linear regression analysis
performed with the GraphPad Prism software package v.5.0.
Comparison of the cell lines sensitivity to chemicals was made
with a two-way Anova test with Dunnett’s post-hoc test and an
unpaired Student’s t-test. The level of statistical signiﬁcance was
set to p < 0.05 (e.g. distinguishing between no observed effect
concentration (NOEC) and lowest-observed-effect concentration
(LOEC)).
The cytokines/chemokines IL-8, IL-6, TNF-alpha, IL-10 and IL-13
were quantiﬁed after the background controls were substracted
from the measured ﬂuorescence values. Cytokine/chemokines
concentrations in sample were determined with a 5-parameter
logistic curve. Final concentrations were calculated from the mean
ﬂuorescence intensity and expressed in pg mL1.
3. Results
3.1. Chemical stability of 4-OPA, 4-AMCH, IPOH in culture medium
determined by GC-FID
The stability of the target chemicals over 24 h was tested by
solubilising the chemicals in the culture medium containing 1 and
10% of FBS. Based on GC-FID methodology (see Materials andFig 1. Stability analysis of 4-OPA, 4-AMCH and IPOH solubilized into the culture medium 
(0, 1, 2, 3, 24 h), (n = 3  STD).methods), the outcomes concerning the LOPs solubilized into the
culture medium showed different stability behaviours over time
(see Fig. 1).
As depicted in Fig. 1, 4-OPA dissolved in the culture medium
containing 10% FBS, suffered a signiﬁcant decrease of more than
50%  2.9 after 24 h. IPOH signiﬁcantly decreased around
50%  5.58, after 24 h, while the reduction of 4-AMCH was
negligible. On the other hand, outcomes from analysis where
the compounds were solubilized into the culture medium
containing 1% FBS, showed that 4-OPA is slightly degraded, around
6%  0.16 after 24 h, while both IPOH and 4-AMCH are the more
stable compounds showing no degradation after 24 h.
The higher concentration of serum (e.g. 10% FBS) added as
cellular nutrient in the cell culture medium showed to inﬂuence
the chemicals stability after 24 h of their preparation in culture
medium, especially for 4-OPA and IPOH. Additional tests on cell
culture growth under the selected culture medium conditions
showed that the reduction of FBS content from 10% to 1% (the
medium with 1% FBS was added to the cells for 24 h—time
corresponding to the treatment time) did not inﬂuence the
viability or the metabolism activity of the cells (data not shown).
Therefore, in order to keep as stable as possible the concentrations
of 4-OPA, IPOH, 4-AMCH during the selected exposure times of
human pulmonary cells to the compounds, the concentration of
FBS added to culture medium was 1%.
3.2. Cellular viability analysis of human pulmonary cells treated with
4-OPA, IPOH and 4-AMCH
As can be observed in Fig. 2, a concentration dependent
decrease in cell viability was observed for both cell lines (A549 and
16HBE14o-) when treated with 4-OPA and IPOH. Within the
concentration range tested, 4-AMCH was found to cause a less
cytotoxic effect (approximately 15% of A549 and 50% 16HBE14o-
loss in cell viability at 5.8 mM) than the other two chemicals. Based
on the curves obtained, the concentration of each chemical where
the cell viability was inhibited by 50% was determined by
calculating the speciﬁc half maximal inhibitory chemical concen-
tration (IC50). The calculated IC50 of 4-OPA for A549 cells was
1.6 mM [95% conﬁdence interval (CI 95%): 1.47–1.78] and forat various concentration of Fetal Bovine Serum (FBS) carried out by GC-FID over time
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Fig. 2. Concentration-response curves obtained from A549 and 16HBE14o- cells exposed to A. 4-AMCH (0.01–5.8 mM), B. 4-OPA (0.2–115 mM), C. IPOH (0.03–17.5 mM). The
dash line represents the trend of 4-parametric sigmoidal curve ﬁt. The results were expressed as percentage (%) of control (untreated cells)  SD of 3 independent experiments
(6 replicates each).
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A549 cells was 3.5 mM [CI 95%: 3.04–4.2] while for 16HBE14o- it
was found to be 3.4 mM [CI 95%: 2.57–4.09]. However, when their
IC50 was compared based on their 95% conﬁdence interval, no
statistical difference between the two cell lines treated with IPOH
was noticed.
Concerning the cellular viability of both cell lines, 16HBE14o-
cells showed a more sensitive reaction than A549 cells (p < 0.005,
one-way analysis of variance (ANOVA) with Tukey’s multiple
comparison test) to 4-OPA treatment at 28.7, 57.5 and 115 mM. The
IC50 of 4-AMCH could not be established in the selected
concentration range (limitation due to its maximum water
solubility of 811 mg L1 at 25 C).
The lowest observed effect concentration (LOEC) which led to a
signiﬁcant decrease of cells viability (p < 0.05) when compared to
untreated cells was 0.9 mM and 0.9 mM for A549 and 16HBE14o-
cells treated with 4-OPA; 1.1 and 0.6 mM for A549 and 16HBE14o-
cells treated with IPOH and 2.9 mM for both cell lines treated with
4-AMCH.3.3. Inﬂammation studies of 4-OPA, IPOH and 4-AMCH on human
pulmonary cells
Concentrations of the selected chemicals greater than 0.5 mM
were found to signiﬁcantly inhibit the cellular viability (p < 0.05).
Therefore, three sub-toxic concentrations (1.5, 50 and 500 mM)
were further used to evaluate their capacity to induce inﬂamma-
tory response in A549 and 16HBE14o- cell lines. No response for
any of the cytokines/chemokines tested: IL-6, IL-8, TNF-alpha, IL-
10 and IL-13 were observed when both cell lines were exposed to
0.5 mM.
As presented in Fig. 3, A549 cells treated with 4-OPA at 1.5 mM
expressed up to 1.3-fold higher levels of IL-8 (p < 0.05), 1.4-fold
higher levels of IL-6 (p < 0.05) and 1.7-fold higher levels of TNF-
alpha (p < 0.01) when compared to the cytokine level determined
in untreated cells (negative control). After treatment with 4-OPA at
50 mM, A549 cells released statistically signiﬁcant levels of IL-6, IL-
8 and TNF-alpha (1.4-fold higher than those of the negative
control, p < 0.05). 16HBE14o- cells released lower amounts of IL-6,
IL-8 and TNF-alpha when exposed to 50 mM of 4-OPA compared to
Fig. 3. Total production of various pro-inﬂammatory cytokines (IL-6, IL-8, TNF-alpha) released by A549 cells after 24-h stimulation with 4-OPA and IPOH at 1.5 and 50 mM.
Cells treated with medium (1% FBS) are expressed as “neg ctrl” = negative control (IL-8 = 132 pg mL1, IL-6 = 81 pg mL1, TNF-a = 12 pg mL1) (n = 9  SD; *p < 0.05, **p < 0.01,
***p < 0.001).
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untreated).
On the other hand, a concentration-dependent effect was
observed in case of IPOH (see Fig. 3). The levels of IL-6 released by
A549 cells were 1.3-times at 1.5 mM IPOH (p < 0.05) and 1.5-times
at 50 mM IPOH higher than the amount found in untreated cells
(p < 0.01). A similar behaviour was observed in 16HBE14o- cells: as
IPOH concentration increased, the amount of IL-8 was increasing
from 2.3-times to 2.8-times (p < 0.001); levels of IL-6 were found
to be approximately 3- and 7-fold change higher than the levels
measured in cell controls; and the amount of TNF-alpha calculated
was 1.4 (p < 0.05) and 1.7-times higher (p < 0.01) (see Fig. 4).
As shown in Table 2, in both cell lines (A549 and 16HBE14o-), 4-
AMCH signiﬁcantly increased the production of TNF-alpha (1.5-
times, p < 0.05) when treatment was done at the higher
concentration tested (50 mM). Enhanced production of IL-6 and
IL-8 (2.5 and 2-times, respectively) was observed in 16HBE14o-
cells treated with 1.5 mM 4-AMCH.
Observing the variations in some of the pro-inﬂammatory
cytokines levels, it was decided to further investigate anti-
inﬂammatory mediators such as IL-10, IL-13. Therefore, ratio
trends of the pro-inﬂammatory cytokines to anti-inﬂammatory
cytokines were calculated for all tested compounds and compared
as follows: IL-8/IL-13, IL-8/IL-10 TNF-alpha/IL-10, TNF-alpha/IL-13,IL-6/IL-10, IL-6/IL-13. A ratio increase (more than 1) of the pro-
inﬂammatory versus anti-inﬂammatory cytokines mentioned
above was considered to represent an inﬂammatory response, as
dictated by the balance between pro and anti-inﬂammatory
biomarkers (Gogos et al., 2000).
As can be seen in Fig. 5, a marked increase in the fold change of
IL-8 versus IL-10 (8.5-times) was found in the bronchial cells
(16HBE14o-) exposed to IPOH compared with the fold-change ratio
of same cytokines released by the A549 cells (IL-8/IL-10 ratio was
1.5). In contrast, both TNF-alpha/IL-10, TNF-alpha/IL-13 fold
changes were found to be at higher levels (3-times) in A549 cells
(see Table 3) than (2- and 1.5-times, respectively) in 16HBE14o-
cells (see Table 4). The data on the fold-change ratio calculated for
4-AMCH show that none of the selected pro-inﬂammatory versus
anti-inﬂammatory cytokines was secreted in bronchial cells.
Moreover, there was no statistically signiﬁcant changes in the
ratio of pro versus anti-inﬂammatory cytokines noted when
bronchial cells were incubated with the tested compounds at
1.5 mM compared to the negative control.
4. Discussion
In the present study, the potential toxic effects of IPOH, 4-
AMCH, 4-OPA regarding cell viability and inﬂammation were
Fig. 4. Total production of various pro-inﬂammatory cytokines (IL-6, IL-8, TNF-alpha) released by 16HBE14o- cells after 24-h stimulation with 4-OPA and IPOH at 1.5 and
50 mM. Cells treated with medium (1% FBS) are expressed as “neg ctrl” = negative control (IL-8 = 161.7 pg mL1, IL-6 = 59.5 pg mL1, TNF-a = 22.5 pg mL1) (n = 9  SD; *p < 0.05,
**p < 0.01, ***p < 0.001).
Table 2
Summary of fold changes calculated for pro- and anti-inﬂammatory markers
released from A549 and 16HBE14o- cells treated with the selected chemicals (4-
OPA, IPOH, 4-AMCH) at different concentrations (1.5 and 50 mM). The values added
in bold represent a fold-change decrease (down-regulation) of the investigated
inﬂammatory markers.
Cell lines Chemical Conc.[mM] Cytokines/chemokines (fold changes)
IL-8 IL-6 TNF-a IL-10 IL-13
A549 IPOH 1.5 1.2 1.3 1.7 1 3
50 1.5 1.5 2.9 1 1
4-OPA 1.5 1.3 1.4 1.7 1 4
50 1.3 1.4 1.4 1 2.7
4-AMCH 1.5 1.2 1.3 8.5 1 4.8
50 1.2 1.2 1.5 1 1
16HBE14o- IPOH 1.5 2.3 3 1.4 4.2 2.6
50 2.8 7 1.7 1.2 1
4-OPA 1.5 2.4 3.3 2.2 3.6 7.3
50 6.1 7.9 4.4 11.6 8.6
4-AMCH 1.5 2 2.5 1 5.6 8
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cell lines of the pulmonary system. The chemicals selected in this in
vitro work are oxidation reaction products of terpenes such as
limonene, [4-OPA (Forester and Wells, 2009), IPOH (Hakola et al.,
1994), 4-AMCH (Hakola et al., 1994)], a-terpineol [4-OPA (Forester
and Wells, 2009)], geraniol [4-OPA (Forester and Wells, 2009)]. Per
se, they might be responsible for certain adverse health effects
linked to terpene-ozone exposure such as: decrease in respiratory
frequency, airﬂow limitations (Wolkoff et al., 2013), skin irritation
and sensitization (Anderson et al., 2010).
Although 4-OPA, IPOH and 4-AMCH were studied in vivo by
murine model (Wolkoff et al., 2013), much less is known about their
potential human lung toxicity. Up to our knowledge,onlyone invitro
study investigated the biological effects (in terms of inﬂammatory
potency) of 4-OPA on A549 cells (Anderson et al., 2010).
To accurately assess the potential public health impacts of
exposure to realistic levels of 4-oxopentanal (4-OPA), 3-isopropenyl-
6-oxoheptanal (IPOH) and 4-acetyl-1-methylcyclohexene (4-
AMCH), the concentrations in various micro-environments where
human exposure can take place must be well-known. At present,
these data are scarcely available. The lowest concentration reported
in the literature regarding 4-OPA was measured in forest environ-
ment (around 0.18 mg m3) (Matsunaga et al., 2004); measured inEuropean ofﬁces, IPOH was found to be in the order of 0.4mg m3,
while 4-AMCH was 0.9mg m3 (Nørgaard et al., 2014).
As it is challenging to convert airborne concentrations to in vitro
medium concentrations that are needed for the in vitro exposure50 7.1 4.5 1.5 1.6 4.3
Fig. 5. Fold change of the pro-inﬂammatory cytokine IL-8 and anti-inﬂammatory cytokine IL-10 ratio for both A549 and 16HBE14o- cell lines treated with 4-OPA, IPOH, 4-
AMCH at 1.5 and 50 mM, in comparison to the corresponding basal ratio of non-exposed cells (negative control).
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concentrations was tested, starting with the maximum chemical’s
solubility in the cellular medium and diluting stepwise. This
resulted in concentration ranges of 0.2–115 mM (4-OPA), 0.03–
17.5 mM (IPOH) and 0.01–5.8 mM (4-AMCH), which were tested on
both bronchial epithelial (16HBE14o-), alveolar epithelial (A549)
cell lines. The mentioned cell lines were chosen to be study as they
are important producers of cytokines—main proteins in lung
defence and inﬂammation (Stadnyk, 1994) and have a central roleTable 3
Summary of pro- and anti-inﬂammatory ratios for A549 cells treated with 4-OPA,
IPOH, 4-AMCH at different concentrations (1.5 and 50 mM). The values added in
bold represent a fold-change decrease (down-regulation) of the investigated
inﬂammatory markers.
A549 cells
4-OPA [uM] IPOH [uM] 4-AMCH [uM]
1.5 50 1.5 50 1.5 50
IL-8/IL-10 1.3 1.3 1.2 1.5 1.3 1.2
IL-8/IL-13 3 2 2.6 1.5 3.9 1.2
IL-6/IL-10 1.4 1.4 1.3 1.5 1.3 1.2
IL-6/IL-13 2.8 1.8 2.3 1.5 3.8 1.2
TNF-a/IL-10 1.7 1.4 1.7 3 8.5 1.6
TNF-a/IL-13 2.4 1.9 1.8 3 4.1 1.6
Table 4
Summary of pro- and anti-inﬂammatory ratios for 16HBE14o- cells treated with 4-
OPA, IPOH, 4-AMCH at different concentrations (1.5 and 50 mM). The values added
in bold represent a fold-change decrease (down-regulation) of the investigated
inﬂammatory markers.
16HBE14o- cells
4-OPA [uM] IPOH [uM] 4-AMCH [uM]
1.5 50 1.5 50 1.5 50
IL-8/IL-10 1.1 71.1 1.4 8.5 2.3 11
IL-8/IL-13 2.2 52.8 1 6.3 3.2 30.2
IL-6/IL-10 1.5 92.3 1.8 3.4 2.8 7.1
IL-6/IL-13 3 68.5 1.2 2.5 4 19.5
TNF-a/IL-10 1.6 51.1 3 2 5.5 1
TNF-a/IL-13 3.2 37.9 1.9 1.5 7.9 2.7in the pathophysiology of asthma (being airway epithelial cells,
represent the ﬁrst line barrier of defence).
In vitro studies require a thorough characterization of chemicals
stability in the stock solution and/or culture medium over cells’
exposure time, since interactions between serum proteins and
chemicals can modify, diminish or invalidate the potentially
adverse effects of chemicals. Furthermore, it is also important to
underline that the nominal concentration in culture medium does
not necessarily correspond to the real concentration to which the
cells are exposed (Kramer et al., 2015). GC-FID analysis showed
(see Fig. 1) that some of the chemicals solubilized in cellular
medium containing 10% FBS were unstable over exposure time,
therefore experiments were carried out in the presence of only 1%
FBS (serum protein’s concentration that did not alter the cellular
viability). The observed reduction of the tested chemicals that
occurs under high serum conditions (e.g. 10% FBS) might be caused
by the interaction of the tested chemicals – classiﬁed as aldehydes
– and the residual amino (NH2) groups on the protein molecules
present in the FBS. This reaction of the aldehyde with a NH2 group
on the protein molecule leads to the formation of a Schiff base (e.g.
a biologically important Schiff base, rhodopsin found in the visual
pigment is formed from the reaction of the aldehyde 11-cis-retinal
with the amino group of lysine, opsin) (Berg et al., 2002).
The selection of the pro- and anti-inﬂammatory cytokines
investigated in the present study takes into account their key role
in pulmonary diseases. Pro-inﬂammatory cytokines have been
postulated to be linked to asthma, pathogenesis of bronchiolitis, in
particular IL-6 and IL-8 (Rincon and Irvin, 2012; Yalcin et al., 2012).
TNF-alpha has been identiﬁed as a key element in various
pulmonary diseases such as acute lung injury, asthma, chronic
bronchitis (Matera et al., 2010; Antoniu et al., 2008; Mukhopad-
hyay et al., 2006). In vivo studies found that high levels of TNF-
alpha causes necrosis in mice (Miyazaki et al., 1995) or induces
severe pro-inﬂammatory reactions (Mukhopadhyay et al., 2006).
The existing literature on anti-inﬂammatory cytokines has
suggested that the increased release of IL-10 (a potent anti-
inﬂammatory cytokine) contributed to the reduction of TNF-alpha
release in alveolar cells (Armstrong et al., 1996) or decreased
production of IL-6 in macrophage (Avdiushko et al., 2001). IL-13
was demonstrated to have a dual role: as pro-inﬂammatory
cytokine, which plays an important role in allergic disease, but it
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suppressing cytotoxic and inﬂammatory functions of monocytes
and macrophages (Cavaillon, 2001) or by limiting the production of
TNF-alpha-induced IL-8 in a whole blood assay (Marie et al., 1996).
Exposure of bronchial cells to high concentrations levels of 4-
OPA [50 mM] showed a down-regulation of IL-6 (6.1-fold change)
and IL-8 (7.9-fold change) when compared to untreated cells. On
the other hand, at the same concentration as 4-OPA, IPOH induced
an increase of both IL-6 and IL-8 secretion in bronchial cells (7-fold
change and 2.8-fold change respectively) which indicates that the
deleterious effect of IPOH is higher in the bronchial cells than in the
alveolar cells, where IL-6 and IL-8 levels were increasing by 1.5-fold
change. A similar behaviour [deleterious effect higher in bronchial
(IL-8 = 2.3- and IL-6 = 3-fold change) than alveolar (IL-8 = 1.2- and
IL-6 = 1.3-fold change) cells] was observed at the lowest tested
concentration for IPOH [1.5 mM]. Concerning the inﬂammatory
effects of 4-AMCH on bronchial cells, only at lowest tested
concentration [1.5 mM], both IL-6 and IL-8 levels were up-
regulated (2-fold change higher than the cells untreated), while
at higher concentration [50 mM] the effects observed were the
opposite (e.g. both IL-6 and IL-8 were approx. 7 and 5-times down-
regulated). On the other hand, 4-AMCH [50 mM] induced increased
levels of TNF-alpha in A549 cells.
In 16HBE14o- cells treated with IPOH at 50 mM, IL-8/IL-10 ratio
was higher than IL-8/IL-13 (1.4-times, p < 0.05), indicating that
IL-10 did not inhibit IL-8 secretion as IL-13 did. Although IL-10 is
considered to have anti-inﬂammatory functions, clinical observa-
tions revealed that IL-10 have also pro-inﬂammatory potential (e.g.
an increased production trend of IL-8 was observed upon IL-10
treatment) (Cooper et al., 2000). Therefore, it might be that IL-10
played its pro-inﬂammatory role while IL-13 served as an anti-
inﬂammatory indicator (Cavaillon, 2001; Marie et al., 1996). Under
our experimental conditions, the ratios of pro-inﬂammatory TNF-
alpha, IL-6 cytokines versus IL-10, IL-13 anti-inﬂammatory were
found to be higher in A549 cells treated with IPOH [50 mM] when
compared to 16HBE14o- cells. Thus, the cellular inﬂammatory
response to IPOH depends on cell type and concentration. In
summary, the ﬁndings of this study regarding the potential
inﬂammatory capacity of the selected chemicals suggest that the
calculated ratio between pro- and anti-inﬂammatory cytokines
caused a relevant increase in the release of inﬂammatory response
in human lung cells.
Results of the in vivo study carried out by Anderson et al.,
showed no signiﬁcant changes in IL-10 amount when mice were
exposed to 4-OPA at 1.97 mM (tested on the mouse ear for dermal
sensitisation) or at 0.08 mM (pulmonary exposure) (Anderson
et al., 2012). Our results concerning the expression of IL-10 in A549
cells when exposed to concentrations covering the range from 0 to
0.5 mM 4-OPA showed no statistically signiﬁcant increase amount
of IL-10.
In one in vitro study, A549 exposed to a gas phase containing
65 ppm 4-OPA released signiﬁcantly increased levels of IL-6
(1059 pg mL1, at 12 h), IL-8 (400 pg mL1, at 24 h) and TNF-alpha
(10 pg mL1, at 24 h) (Anderson et al., 2010). As showed in Results
section, 4-OPA tested at a low concentration [1.5 mM], signiﬁcantly
altered all the selected pro-inﬂammatory cytokines as follows: IL-6
(116 pg mL1, at 24 h), IL-8 (167 pg mL1, at 24 h), and TNF-alpha
(20.1 pg mL1, at 24 h). At a higher concentration of 4-OPA
[50 mM], after 24 h, the amount of IL-6 was not statistically
different when compared to the IL-6 amount obtained after 4-OPA
treatment at 1.5 mM, while TNF-alpha levels slightly decreased
(17.2 pg mL1, p < 0.05).
Among the tested compounds, IPOH has proven to have the
strongest potency for induction of inﬂammatory cytokines IL-6 and
IL-8 (e.g. approximately 200-fold change increase of IL-6 for
16HBE14o- cells stimulated with IPOH when compared to16HBE14o- cells treated with 4-OPA) whereas 4-OPA demonstrat-
ed the strongest cell viability destruction of A549 cells with a IC50
at 1.6 mM (when compared to IC50 IPOH = 3.5 mM and IC50 4-AMCH
could not be established).
In conclusion, the ﬁndings of the present study demonstrate, for
the ﬁrst time, to the best of our knowledge, that at 50 mM both 4-
OPA and 4-AMCH inhibited the expression of IL-6, IL-8, TNF-a in
16HBE14o- cells, but not in A549 cells. On the other hand, IPOH
[50 mM] was stimulating IL-6, IL-8 and TNF-a release from both
16HBE14o- and A549 cell lines, suggesting that IPOH is likely to
contribute to the pathogenesis of human airway inﬂammatory
disorders. The results regarding the inﬂammatory capacity of IPOH
agree reasonably well with the recent observations made by
Wolkoff et al. regarding the awareness on IPOH (based on his in
vivo results, IPOH might cause sensory irritation) (Wolkoff et al.,
2013).
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